- Denis L, Griffiths K, Khoury S, Cockett ATK, McConnell, Chatelain C, et al. In: 4th International Consultation on Benign Prostatic Hyperplasia (BPH), Proceedings 4. Plymebridge Distributors Ltd, Plymouth, United Kingdom, 1998.
- Kirby R, Christmas T, Brawer M. Chapter 3. In: Prostate Cancer, Mosby, an imprint of Times Mirror International Publishers Limited, 1996.
- McNeal J. Pathology of benign prostatic hyperplasia. Urol. Clin. N. Am. 1990; 17: 477-86.
- Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, et al. Latent carcinoma of the prostate at autopsy in seven areas. Int. J. Cancer 1977; 20: 680-8.
- Armenian HK, Lilenfeld AM, Diamond EL, Bross IDJ. Relation between benign prostatic hyperplasia and cancer of the prostate. Lancet 1974; 2: 115-17.
- Tiblin G. Prostatic cancer: the men born in 1913 study. In: Medical Products Agency: workshop: pharmacological treatment of prostatic cancer, Vol. 3. Uppsala, Sweden: Medical Products Agency. 1993: 13-9.
- Greenwald P, Kirmss V, Polan AK, Dick VS. Cancer of the prostate among men with benign prostatic hyperplasia. J. Natl. Cancer Inst. 1974; 53: 335-40.
- Hammarsten J, Andersson S, Holmén A, Högstedt B, Peeker R. Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? A 10-year follow-up study. Cancer 1994; 74: 2347-51.
- Lund K, Ewertz M, Schou G. Breast cancer incidence subsequent to surgical reduction of the female breast. Scand. J. Plast. Reconstr. Surg. 1987; 21: 209-12.
- Mostofi FK, Sesterhenn I, Sobin LH. Histological typing of prostate tumours, International histological classification of tumors No.> 22, WHO, Geneva, 1980.
- Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl. 1992; 4: 129-38.
- Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening--Part II. Accuracy of in vitro and in vivo techniques. Radiology 1991; 179: 49-53.
- Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J. Urol. 1991; 145: 984-7.
- Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J. Urol. 1984; 132: 474-9.
- Gay JM. Clinical epidemiology and evidence-based medicine glossary. In: Terminology Specific to Epidemiology, updated August 22, 1999, page 2 http:// www.vetmed.wsu.edu./courses-jmgay/GlossEpiTerminology.htm
- Hammarsten J, Högstedt B, Holthuis N, Mellström D. Components of the metabolic syndrome--risk factors for the development of benign prostatic hyperplasia. Prostate cancer and prostatic diseases 1998; 1: 157-62.
- Hammarsten J, Högstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood pressure 1999; 8: 29-36.
- Hammarsten J, Högstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. European Urology 2001; 39: 151-8.
- Reavan GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
- Rett K, Wicklmayr M, Mehnert H. New aspects of insulin resistance in hypertension. European Heart Journal 1994; 15 (Supplement C): 78-81.
- DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 ;14: 173-94.
- Krotkiewski M. Role of muscle capillarization and morphology in the development of insulin resistance and metabolic syndrome. Presse Med. 1994; 23: 1353-6.
- Timar O, Sestier F, Levy E. Metabolic syndrome X: a review. Can. J. Cardiol. 2000; 16: 779-89.
- Lithell H. In: Insulinresistens. En bas för förståelsen av kardiovaskuläre sjukdomars etiologi och behandling. Bristol-Myers Squibb AB 1992.
- Gleason DF. Histologie grading of prostate cancer: a perspective. Human Pathology 1992; 23: 273-9.
- Morton MS, Blacklock N, Denis E, Griffiths K. Western diet and prostate cancer: does the available evidence justify dietary advice. In: Schröder FH. Recent advances in prostate cancer and BPH. New York: The Parthenon Publishing Group Inc., 1996: 61-74.
- Kalkhoff RK, Kim HJ, Cerletty J, Ferrou CA. Metabolic effects of weight loss in obese subjects. Changes in plasma substrate levels, insulin and growth hormone responses. Diabetes 1971; 20: 83-91.
- Nilsson PM, Eindholm EH, Scherstén BF. Life style changes improve insulin resistance in hyperinsulinaemic subjects: a one-year intervention study of hypertensives and normotensives in Dalby. J. Hypertens. 1992; 10: 1071-78.
- Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A. Effects of weight loss in massive obesity on insulin and c-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. Endocrinol Metab. 1987; 64: 661-8.
Calculated Fast-growing Benign Prostatic Hyperplasia
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.